BMI OrganIQ is the artificial-intelligence layer of BMI OrganBank's integrated kidney organ-banking solution, listed by the Winston-Salem, North Carolina company as a future-pipeline offering. The tool is designed to draw on BMI's proprietary clinical study data sets to estimate organ viability and transplant success rates, to integrate with the OrganBank Monitor perfusion device for real-time decision support, and to pair with a mobile app that puts those estimates in front of clinicians at the point of decision.
The offering targets kidney-first transplant programs working to reduce organ discard by quantifying organ quality before implantation, complementing the company's OrganBank Kidney perfusion platform, OrganBank Monitor, and OrganBank Transport hardware. BMI OrganBank's materials describe the commercial product in the envisaged tense with computer-generated concept imagery, and no launch date or regulatory submission had been announced for OrganIQ as of September 2026.

Planned BMI OrganBank AI tool to predict donor-kidney transplant outcomes and organ viability.


XVIVO portable hypothermic machine perfusion device preserving donor kidneys for up to 24 hours.


Organ Recovery Systems portable hypothermic perfusion transporter for donor kidneys with live resistance metrics.


Waters Medical Systems FDA-cleared hypothermic perfusion platform for one or two donor kidneys.
XVIVO portable hypothermic machine perfusion device preserving donor kidneys for up to 24 hours.

Organ Recovery Systems portable hypothermic perfusion transporter for donor kidneys with live resistance metrics.

Waters Medical Systems FDA-cleared hypothermic perfusion platform for one or two donor kidneys.



Paragonix KidneyVault is an FDA-cleared portable pulsatile hypothermic perfusion system for donor kidneys.
Paragonix KidneyVault is an FDA-cleared portable pulsatile hypothermic perfusion system for donor kidneys.
